Sandoz Capecitabine 150 mg – DIN 02421917
Sandoz Capecitabine is Capecitabine 150 mg (tablet), sold in Canada. It is used for breast cancer and colorectal cancer. It is supplied by Sandoz Canada Incorporated. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Capecitabine 150 mg
- Brand
- Sandoz Capecitabine
- Strength
- 150 mg
- Used for
- Breast cancer and colorectal cancer
- Form
- Tablet
- Manufacturer
- Sandoz Canada Incorporated
- Drug class
- Nucleoside metabolic inhibitor
- Sold in
- Canada
- DIN
- 02421917
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Capecitabine used for?
Capecitabine is used for breast cancer and colorectal cancer.
- Medicine type
- Nucleoside metabolic inhibitor
Official uses from the US prescribing label
Colorectal Cancer
Capecitabine tablets are indicated for the:
- adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component of a combination chemotherapy regimen.
- perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy.
- treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen.
Breast Cancer
Capecitabine tablets are indicated for the:
- treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated.
- treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy.
Gastric, Esophageal, or Gastroesophageal Junction Cancer
Capecitabine tablets are indicated for the:
- treatment of adults with unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer as a component of a combination chemotherapy regimen.
- treatment of adults with HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma who have not received prior treatment for metastatic disease as a component of a combination regimen.
Pancreatic Cancer
Capecitabine tablets are indicated for the adjuvant treatment of adults with pancreatic adenocarcinoma as a component of a combination chemotherapy regimen.
From the FDA-approved label on DailyMed (published Jul 22, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02421917.
- It names Sandoz Capecitabine, Capecitabine 150 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Sandoz Capecitabine by Sandoz Canada Incorporated.
In Canada: prescription only.
Ingredients
Active: Capecitabine
Other Capecitabine pills
-
191 77
Capecitabine 500 mg
Orange, capsule, 16 mm
Used for breast cancer and colorectal cancer
- XELODA 150 Capecitabine 150 mg Pink, oval, 11 mm Used for breast cancer and colorectal cancer
- CAP 150 Capecitabine 150 mg Pink, capsule, 11 mm Used for breast cancer and colorectal cancer
- C150 Capecitabine 150 mg Pink, capsule, 11 mm Used for breast cancer and colorectal cancer
- 150 Capecitabine 150 mg Pink, oval, 11 mm Used for breast cancer and colorectal cancer
- C 150 Capecitabine 150 mg Orange, capsule, 11 mm Used for breast cancer and colorectal cancer
- C150 Capecitabine 150 mg Pink, capsule, 11 mm Used for breast cancer and colorectal cancer
- A015 Capecitabine 150 mg Pink, oval, 11 mm Used for breast cancer and colorectal cancer